RP Bio Inc. (KOSDAQ:314140)
5,330.00
-150.00 (-2.74%)
At close: Jul 10, 2026
-8.73% (1Y)
| Market Cap | 46.19B -6.7% |
| Revenue (ttm) | 137.35B +9.5% |
| Net Income | 5.60B +328.6% |
| EPS | 647.79 +328.4% |
| Shares Out | 8.67M |
| PE Ratio | 8.23 |
| Forward PE | n/a |
| Dividend | 50.00 (0.91%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 14,628 |
| Open | 5,440.00 |
| Previous Close | 5,480.00 |
| Day's Range | 5,260.00 - 5,500.00 |
| 52-Week Range | 4,810.00 - 9,130.00 |
| Beta | 0.47 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |